1
|
Onofri A, Necozione S, Tozzi E. Complementary and alternative medicine (CAM) in headache of children and adolescents: open-label Italian study. Clin Ter 2020; 171:e393-e398. [PMID: 32901780 DOI: 10.7417/ct.2020.2246] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE The aim of the present research is to evaluate and to compare various nutraceuticals and food supplements in the headaches prophylaxis. BACKGROUND Recently the use of complementary and alternative medicine, nutraceuticals and food supplements, in prophylaxis and attack therapy of headaches is spreading both in adulthood and in childhood age. MATERIALS AND METHODS 99 children, 6-17 years, females 44 and males 55, suffering from primary headaches and admitted to Headache Center in the years 2016- 2017 are the sample. 7 patients were excluded because they did not adhere to the study due to lack of therapeutic compliance and because they did not return to clinical controls. The patients referred to the Headache Center are selected consecutively. The open-label study evaluating clinical trial concerns the evaluation of the following parameters: headache diagnosis according to International Headache Society criteria (ICHD-III, 2013 beta version), migraine index; the prophylaxis and attack therapies at time zero and after 12 months. The compounds used to prophylaxis therapy are: Mg citrate, Mg oxide and Mg aspartate (compound n°1), Bisglycinate Mg + L-Tryptophan + Niacin + B2 Vitamin + D Vitamin (compound n°2), Oxide Mg + Partenium + Andrographis paniculata + coenzyme Q10, B2 Vitamin (compound n°3). Each compound was compared with the other to evaluate clinical efficacy. Attack therapy: Paracetamol, Ibuprofen, ketoprofen, Indomethacin. Informed consent was obtained for participation in the study by the parents of the children. Statistical analysis is made by Kruskal -Wallis test and analysis post hoc Conover. RESULT 22 females and 24 males suffer from Migraine without aura, 9 females and 12 males from Migraine with Aura, 11 females and 14 males from Tension Type Frequent Headache. The therapy as with compounds n°1, 2 and 3 is effective in reducing migraine index and reduces the use of attack therapy in all the cases very significantly (p=0.000001). In MwoA the compound n° 1 is less effective than compounds n° 2 and 3(p=0.00089).In MA compound n° 3 is less effective than compounds n° 2 and 1 (p=0.0044). In FETTH, compound n° 3 is less effective compared to compound n° 2 (p=0.052). CONCLUSION The use of nutraceuticals and food supplements appears to be effective and also encouraging as it is well accepted by parents and children themselves.
Collapse
Affiliation(s)
- A Onofri
- Neuropsychiatric Clinic, Department of Life, Health and Environmental Sciences, University of L'Aquila
| | - S Necozione
- Epidemiology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy
| | - E Tozzi
- Neuropsychiatric Clinic, Department of Life, Health and Environmental Sciences, University of L'Aquila
| |
Collapse
|
2
|
Pecorelli I, Branciari R, Roila R, Bibi R, Ranucci D, Onofri A, Valiani A. Evaluation of Aflatoxin M 1 Enrichment Factor in Semihard Cow's Milk Cheese and Correlation with Cheese Yield. J Food Prot 2019; 82:1176-1182. [PMID: 31233360 DOI: 10.4315/0362-028x.jfp-19-023] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
HIGHLIGHTS The aflatoxin M1 content in milk was not related to the enrichment factor. The enrichment factor in 45-day ripened semihard cheese was defined. The enrichment factor in cheese is affected by cheese yield.
Collapse
Affiliation(s)
- I Pecorelli
- 1 Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati," Via G. Salvemini 1, 06126 Perugia, Italy
| | - R Branciari
- 2 Department of Veterinary Medicine, University of Perugia, Via San Costanzo, 4-06126 Perugia, Italy (ORCID: https://orcid.org/0000-0002-4428-9016 [R. Branciari])
| | - R Roila
- 2 Department of Veterinary Medicine, University of Perugia, Via San Costanzo, 4-06126 Perugia, Italy (ORCID: https://orcid.org/0000-0002-4428-9016 [R. Branciari])
| | - R Bibi
- 1 Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati," Via G. Salvemini 1, 06126 Perugia, Italy
| | - D Ranucci
- 2 Department of Veterinary Medicine, University of Perugia, Via San Costanzo, 4-06126 Perugia, Italy (ORCID: https://orcid.org/0000-0002-4428-9016 [R. Branciari])
| | - A Onofri
- 3 Department of Agricultural, Food and Environmental Sciences, University of Perugia, Borgo XX Giugno, 74-06121 Perugia, Italy
| | - A Valiani
- 1 Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati," Via G. Salvemini 1, 06126 Perugia, Italy
| |
Collapse
|
3
|
Torniai M, Savini A, Morgese F, Rinaldi S, Rubini C, Santoni M, Onorati S, Pompili S, Onofri A, Scarpelli M, Berardi R. Prognostic relevance of VEGF, VEGFR, IGF and IGFR immunohistochemical expression in gastroenteropancreatic neuroendocrine tumors. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
4
|
Rinaldi S, Santoni M, Armento G, Torniai M, Morgese F, Leoni G, Fiordoliva I, Paolucci V, Savini A, Onofri A, Santini D, Berardi R. Prognostic impact of hyponatremia in patients affected by advanced non-small cell lung cancer (NSCLC) with bone metastases (BMs). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx426.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
5
|
Onofri A, Patout M, Arbane G, Pengo M, Marino P, Steier J. S56 Neural respiratory drive and cardiac function in patients with obesity-hypoventilation-syndrome following setup of non-invasive ventilation for hypercapnic respiratory failure. Thorax 2016. [DOI: 10.1136/thoraxjnl-2016-209333.62] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
6
|
Savini A, Torniai M, Pagliaretta S, Rinaldi S, Morgese F, Caramanti M, Santoni M, Onorati S, Pompili S, Onofri A, Berardi R. Impact of VEGF and VEGFR single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine tumors. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw333.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
7
|
Torniai M, Piva F, Rinaldi S, Santoni M, Pagliaretta S, Partelli S, Savini A, Morgese F, Caramanti M, Pistelli M, Bittoni A, Giampieri R, Onofri A, Pezzulla D, Principato G, Falconi M, Berardi R. Pathogenic and prognostic role of VEGF and VEGFR single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine neoplasms. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw333.27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
8
|
Morgese F, Pagliaretta S, Rinaldi S, Torniai M, Savini A, Onofri A, Soldato D, Fabbri A, Berardi R. Phosphoinositide-3-kinase single-nucleotide polymorphisms frequencies between malignant melanoma patients and healthy volunteers shared by sex. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw341.03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
9
|
Forte C, Acuti G, Manuali E, Casagrande Proietti P, Pavone S, Trabalza-Marinucci M, Moscati L, Onofri A, Lorenzetti C, Franciosini MP. Effects of two different probiotics on microflora, morphology, and morphometry of gut in organic laying hens. Poult Sci 2016; 95:2528-2535. [PMID: 27143778 DOI: 10.3382/ps/pew164] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/19/2016] [Indexed: 11/20/2022] Open
Abstract
The current study investigated the effects of Lactobacillus acidophilus and Bacillus subtilis, used as probiotics, on the microflora, morphology, and morphometry of the gut in organic laying hens. The birds (180 Hy-Line laying hens) were divided into 3 homogenous groups and received a pre-deposition diet from 16 to 20 wk of age and a deposition diet for the remaining 7 months of the experiment. The control group ( CTR: ) was fed a corn-soybean cake-based diet, the second group ( L: ) received the same diet supplemented with 0.1% of L. acidophilus while in the third group ( B: ) the basal diet was supplemented with 0.05% of B. subtilis At 18 wk of age ( T1: ) and at 5 ( T2: ) and 7 months ( T3: ) from the beginning of deposition, 9 subjects per group were humanely killed for microbiological, morphological and morphometric analyses of the intestinal tract. The 2 probiotic-supplemented diets increased Lactobacillus spp. and Bifidobacterium spp. counts compared with the CTR diet. The lowest viable counts of E. coli, coliforms and staphylococci were observed in the L group (P < 0.001). Clostridium spp. decreased (P < 0.001) in both L and B subjects. The probiotic supplementation appeared to affect the intestinal microbial population, promoting the presence of beneficial bacteria such as Lactobacillus spp. and Bifidobacterium spp. and reducing potential harmful bacteria such as E. coli, clostridia and staphylococci. Morphological and morphometric analyses did not reveal substantial differences among groups. At T3, the plasma cell infiltrate in the villi of the CTR hens was more severe than that observed in the L and B groups (P = 0.009).
Collapse
Affiliation(s)
- C Forte
- Department of Veterinary Medicine, University of Perugia, Italy
| | - G Acuti
- Department of Veterinary Medicine, University of Perugia, Italy
| | - E Manuali
- Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche, Perugia, Italy
| | | | - S Pavone
- Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche, Perugia, Italy
| | | | - L Moscati
- Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche, Perugia, Italy
| | - A Onofri
- Department of Agricultural, Food and Environmental Sciences, University of Perugia, Italy
| | - C Lorenzetti
- Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche, Perugia, Italy
| | - M P Franciosini
- Department of Veterinary Medicine, University of Perugia, Italy
| |
Collapse
|
10
|
Caramanti M, Berardi R, Santoni M, Newsom-Davis T, Rinaldi S, Savini A, Tiberi M, Morgese F, Torniai M, Fiordoliva I, Paolucci V, Pistelli M, Onofri A, Bower M, Cascinu S. Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv343.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
11
|
Rinaldi S, Berardi R, Santoni M, Morgese F, Torniai M, Fiordoliva I, Caramanti M, Paolucci V, Savini A, Onofri A, Santini D, Armento G, Cascinu S. Bone metastases (BMs) in patients with advanced non-small cell lung cancer (NSCLC): do they always correlate with poor prognosis? Ann Oncol 2015. [DOI: 10.1093/annonc/mdv343.40] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
12
|
Torniai M, Berardi R, Brunelli A, Pagliaretta S, Paolucci V, Conti A, Goteri G, Refai M, Pompili C, Marcantognini G, Morgese F, Savini A, Caramanti M, Santoni M, Zizzi A, Mazzanti P, Onofri A, Sabbatini A, Scarpelli M, Cascinu S. Impact and prognostic role of single-neucleotide polymorphisms (SNPs) in thymic lesions. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv343.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
13
|
Fiordoliva I, Berardi R, Ballatore Z, De Lisa M, Caramanti M, Morgese F, Savini A, Rinaldi S, Torniai M, Tiberi M, Ferrini C, Onofri A, Cascinu S. Clinical and pathological predictors of outcome for malignant pleural mesothelioma. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv343.50] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
14
|
Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M, Morgese F, Torniai M, Savini A, Onofri A, Pistelli M, Taccaliti A, Cascinu S. Risk for developing hyponatraemia in cancer patients treated with targeted therapies: a meta-analysis. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv348.12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Pompili C, Salati M, Refai M, Berardi R, Onofri A, Mazzanti P, Brunelli A. Preoperative quality of life predicts survival following pulmonary resection in stage I non-small-cell lung cancer. Eur J Cardiothorac Surg 2012; 43:905-10. [DOI: 10.1093/ejcts/ezs532] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
16
|
Berardi R, Santinelli A, Caramanti M, Savini A, Onofri A, Biscotti T, Brunelli A, Mazzanti P, Bearzi I, Cascinu S. The Role of Hedgehog (HH) Signaling in the Prediction of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)34207-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
17
|
Masini C, Milella M, Di Lorenzo G, Onofri A, Santoni M, Prati V, Nicodemo M, Conte P, Sabbatini R. Treatment of Patients with Metastatic Kidney Cancer During Haemodialysis with mTOR Inhibitors. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33453-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
18
|
Pavone S, Gialletti R, Pepe M, Onofri A, Mandara M. Histological and immunohistochemical studies of changes in myenteric plexuses and in interstitial cells of Cajal associated with equine colic. Res Vet Sci 2012; 93:350-9. [DOI: 10.1016/j.rvsc.2011.07.019] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2010] [Revised: 07/18/2011] [Accepted: 07/22/2011] [Indexed: 11/28/2022]
|
19
|
Campanati A, Berardi R, Onofri A, Pierantoni C, Conte I, Giuliodori K, Molinelli E, Marcucci F, Cascinu S, Offidani A. A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. Ann Oncol 2012; 23:1081-2. [PMID: 22457259 DOI: 10.1093/annonc/mds026] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
20
|
Santoni M, Paccapelo A, Burattini L, Onofri A, Cascinu S. Twice-daily dosing of temozolomide in combination with fotemustine for the treatment of patients with refractory glioblastoma. Anticancer Res 2012; 32:1099-1101. [PMID: 22399639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Alkylating agents, such as temozolomide (TMZ) and fotemustine (FTM) are widely used in recurrent glioblastoma (GBM) regimes. Several strategies have been proposed to prevent resistance to these agents, by combining or sequencing them. We report the results of a pilot study of patients with refractory GBM receiving a regime of twice-daily dosing of temozolomide administered on day 1, (with an initial oral dose of 200 mg/m(2) and a second oral dose of 75 mg/m(2) 12 h later), followed by fotemustine in a single i.v. infusion at 75 mg/m(2) on day 2, repeated every four weeks. Enrolment was stopped at 15 patients due to lack of effectiveness of this schedule for patients with GBM. Toxicity was mild, with no grade 4 side effects reported. Results indicate that our temozolomide -FTM combined schedule is not effective, although well tolerated, in non responsive patients with GBM. Further strategies are required to improve the outcome of these patients.
Collapse
Affiliation(s)
- M Santoni
- Department of Medical Oncology, Polytechnic University of the Marche Region, Azienda Ospedaliero-Universitaria, Ospedali Riuniti Umberto I-GM Lancisi and G Salesi, Ancona, Italy.
| | | | | | | | | |
Collapse
|
21
|
Berardi R, Onofri A, Savini A, Caramanti M, Chiorrini S, Santinelli A, Brunelli A, Zuccatosta L, Mazzanti P, Pierantoni C, Scartozzi M, Sabbatini A, Gasparini S, Cascinu S. Relationship of number of resected lymph nodes in early-stage non-small cell lung cancer (NSCLC) and survival. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e17509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
22
|
De Braud FG, Catania C, Onofri A, Pierantoni C, Cascinu S, Maur M, Masini C, Conte PF, Giovannoni L, Tasciotti A, Lovato V, Neri D, Menssen HD. Combination of the immunocytokine F16-IL2 with doxorubicin or paclitaxel in patients with solid tumors: Results from two phase Ib trials. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.2595] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
23
|
Berardi R, Campanati A, Onofri A, Bittoni A, Pierantoni C, Giuliodori K, Ganzetti G, Scartozzi M, Offidani A, Cascinu S. A novel approach to manage skin toxicity caused by cetuximab and panitumumab. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.4_suppl.616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
616 Background: Inhibition of the EGFR represents one of the most important fields for research and development in cancer therapy. Skin rash has been documented as one of the most common adverse reactions in patients receiving EGFR inhibitors. Several approaches have been attempted to manage skin toxicity. Nicotinamide has been shown to be an effective treatment for skin inflammation in various conditions, since nicotinamide inhibits IL-8 production through the NF-kB and MAPK pathways in an in vitro keratinocytes/P. acnes model of inflammation. Furthermore green tea polyphenols could be useful in attenuation of solar UVB light-induced oxidative stress-mediated and MAPK-caused skin disorders in humans. Methods: Therapy protocol for skin toxicity consisted of: topic applications of green tea and a mostouizer and orally given nicotinamide. Patients were monitored weekly and data regarding skin toxicity (NCI-CTC grade, the Dermatology Life Quality Index (DLQI), a global score evaluating all the parameters) were recorded. Results: Between September 2009 and September 2010, 13 colorectal cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab) and developing skin toxicity, were treated by a multidisciplinary team including oncologists, dermatologists, a pathologist, and a nurse. All the patients experienced a significative eduction of erythema, papulo-pustular rash, paronychia, fissuring, xerosis, and itching. A significative improvement of the global score and of DLQI was evident. No toxicity related to the treatment of skin toxicity was observed. Conclusions: Treatment with nicotinamide, green tea, and moisturizer represents a novel effective approach to manage skin toxicity caused by cetuximab and panitumumab. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- R. Berardi
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| | - A. Campanati
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| | - A. Onofri
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| | - A. Bittoni
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| | - C. Pierantoni
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| | - K. Giuliodori
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| | - G. Ganzetti
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| | - M. Scartozzi
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| | - A. Offidani
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| | - S. Cascinu
- Clinica di Oncologia Medica, A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Clinica di Dermatologia, Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy; Scuola di Specializzazione in Oncologia, Università Politecnica delle Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy; A. O. Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy
| |
Collapse
|
24
|
Scartozzi M, Loretelli C, Bearzi I, Mandolesi A, Galizia E, Onofri A, Pistelli M, Bittoni A, Berardi R, Cascinu S. Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. Ann Oncol 2010; 22:897-902. [PMID: 20926544 DOI: 10.1093/annonc/mdq542] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
BACKGROUND Preclinical studies suggested that integrins are relevant for gastric cancer diffusion. We investigated integrins polymorphisms role in determining peritoneal carcinosis or hematogenous metastases in radically resected gastric cancer. PATIENTS AND METHODS Integrins genotyping was carried out on pT3 radically resected gastric tumors recurring with either peritoneal-only carcinosis or hematogenous metastases. RESULTS The following factors resulted independently associated with peritoneal carcinosis or hematogenous metastases: the A genotype of rs2269772 (ITGA3) [odds ratio (OR) for peritoneal carcinosis: 22.2, 95% confidence interval 1.2-40, P=0.03], the G genotype of rs2269772 (ITGA3) (OR for hematogenous metastases: 5.5, 95% confidence interval 2.2-14.15, P=0.0003), the C genotype of rs11902171 (ITGV) (OR for peritoneal carcinosis: 6.8, 95% confidence interval 1.3-33.4, P=0.01), the G genotype of rs11902171 (ITGV) (OR for hematogenous metastases: 2.5, 95% confidence interval 1.1-5.7, P = 0.02), diffuse histology (OR for peritoneal carcinosis: 4.7, 95% confidence interval 1.9-11.3, P=0.0005) and intestinal histology (OR for hematogenous metastases: 4.2, 95% confidence interval 1.9-9.9, P=0.0008). CONCLUSIONS Tumor histology represents a crucial issue conditioning tumoral behavior; genotyping of rs2269772 (ITGA3) and rs11902171 (ITGV) may be a further asset in the definition of high-risk patients for peritoneal carcinosis among those relapsing after curative resection. The selection tool deriving from this analysis may allow an optimal use of innovative treatment strategies.
Collapse
Affiliation(s)
| | | | - I Bearzi
- Department of Pathology, United Hospitals, Polytechnic Marche University, Ancona
| | - A Mandolesi
- Department of Pathology, United Hospitals, Polytechnic Marche University, Ancona
| | - E Galizia
- Department of Medical Oncology, Profili Hospital, Fabriano
| | - A Onofri
- Postgraduate School in Medical Oncology, United Hospitals, Polytechnic Marche University, Ancona, Italy
| | - M Pistelli
- Postgraduate School in Medical Oncology, United Hospitals, Polytechnic Marche University, Ancona, Italy
| | - A Bittoni
- Postgraduate School in Medical Oncology, United Hospitals, Polytechnic Marche University, Ancona, Italy
| | | | | |
Collapse
|
25
|
Berardi R, Mandolesi A, Onofri A, Maccaroni E, Mantello G, Bearzi I, Scartozzi M, Pierantoni C, Marmorale C, Cascinu S. Nuclear factor-kB (NF-kB), p53, survivin, Ki-67, and Bcl-2 as prognostic factors in locally advanced rectal cancer patients receiving radiochemotherapy. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e22062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e22062 Background: NF-kB, p53, Survivin, Ki-67 and Bcl-2 expressions have been demonstrated to be prognostic factors in solid tumors. The aim of our analysis was to investigate the importance of their expression, as prognostic factors in patients with locally advanced rectal cancer patients receiving receiving neoadjuvant radiochemotherapy Methods: We analyzed the expression of NF-kB, p53, Survivin, Ki-67 and Bcl-2 in patients with locally advanced rectal cancer who underwent neoadjuvant treatment (radiotherapy ± chemotherapy) at our Department Results: Seventy-four patients were eligible for our analysis. Median age at diagnosis was 66 years (range 36–85). Male/female ratio was 47/37; 37 patients (90%) were diagnosed with adenocarcinoma, whilst 4/41 (10%) with mucinous adenocarcinoma. All the patients received radiotherapy ± 5-fuorouracil/capecitabile-based chemotherapy. Median follow up was 28 months (range 6,7–56,6 months). At univariate and multivariate analysis of the above mentioned parameters, NF-kB, Ki67 and bcl-2 showed an impact on outcome.In particular, in NF-kB-strongly positive patients time to progression (TTP) and overall survival were significantly shorter (p=0,011 and p=0,018 respectively). Moreover a high expression of Ki-67 and a low expression of bcl-2 were associated with a better TTP Conclusions: Our results suggest that NF-kB, bcl-2 and Ki-67 could represent important parameters able to predict the outcome in patients receiving neoadjuvant treatment for rectal cancer. Further prospective studies are warranted in order to confirm the prognostic role of the above mentioned factors in this setting. This could be useful in order to select patients to receive adjuvant chemotherapy after neoadjuvant treatment and surgery for locally advanced rectal cancer, intensifying the adjuvant therapy in some groups of patients and obviating the use of the some drugs (i.e. those involving NF-kB in their mechanism of action) in selected patients No significant financial relationships to disclose.
Collapse
Affiliation(s)
- R. Berardi
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| | - A. Mandolesi
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| | - A. Onofri
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| | - E. Maccaroni
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| | - G. Mantello
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| | - I. Bearzi
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| | - M. Scartozzi
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| | - C. Pierantoni
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| | - C. Marmorale
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| | - S. Cascinu
- Università Politencnica Marche, Ancona, Italy; Ospedali Riuniti di Ancona, Ancona, Italy
| |
Collapse
|
26
|
Berardi R, Mandolesi A, Bearzi I, Scartozzi M, Mantello G, Onofri A, Pierantoni C, Marmorale C, Fianchini A, Cascinu S. Nuclear factor-kB (NF-kB) predicts outcome in locally advanced rectal cancer patients receiving radio-chemotherapy. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.22122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
27
|
Berardi R, Brunelli A, Tamburrano T, Verdecchia L, Onofri A, Zuccatosta L, Gasparini S, Santinelli A, Scartozzi M, Valeri G, Giovagnoni A, Giuseppetti GM, Fabris G, Marmorale C, Fianchini A, Cascinu S. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Lung Cancer 2006; 49:371-6. [PMID: 15951051 DOI: 10.1016/j.lungcan.2005.04.011] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2005] [Revised: 04/20/2005] [Accepted: 04/21/2005] [Indexed: 11/25/2022]
Abstract
We hypothesised that anemia could represent an important prognostic factor and perioperative blood transfusions do not reduce the risk of relapse. In order to explore this topic, we assessed the correlation of preoperative anemia and blood transfusions with survival in patients with resected non-small cell lung cancer (NSCLC). Patients who underwent radical surgery for NSCLC at the Department of Thoracic Surgery of Università Politecnica delle Marche from January 1996 through December 2001, were included in our study. Four hundred and thirty-nine patients were eligible for our analysis. Survival appeared worse in patients with haemoglobin (Hb) < or =10 g/dl versus Hb >10 g/dl (p=0.012). Stratifying patients in three groups on their Hb level (group 1: Hb < or =10 g/dl; group 2: Hb=10-12 g/dl; group 3: Hb > or =12 g/dl), we observed a worse prognosis in patients with lower Hb levels, too (p=0.0325) and also in the transfused population (p=0.046). At multivariate analysis, only the age of patients, pathological stage and Hb levels resulted indicators of prognosis. Our results suggested that anemia could represent an important prognostic factor in resected NSCLC and correction of anemia in the perioperative setting does not reduce the risk of relapse.
Collapse
Affiliation(s)
- R Berardi
- Clinica di Oncologia Medica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I--Lancisi--Salesi, Ancona, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Berardi R, Tamburrano T, Fianchini A, Verdecchia L, Onofri A, Santinelli A, Scartozzi M, Cellerino R, Cascinu S. Perioperative anemia as prognostic factor in patients undergoing resection for non-small cell lung cancer. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.7179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- R. Berardi
- Universita' Politecnica delle Marche, Ancona, Italy
| | | | - A. Fianchini
- Universita' Politecnica delle Marche, Ancona, Italy
| | | | - A. Onofri
- Universita' Politecnica delle Marche, Ancona, Italy
| | | | - M. Scartozzi
- Universita' Politecnica delle Marche, Ancona, Italy
| | - R. Cellerino
- Universita' Politecnica delle Marche, Ancona, Italy
| | - S. Cascinu
- Universita' Politecnica delle Marche, Ancona, Italy
| |
Collapse
|
29
|
Abstract
BACKGROUND Advances in paediatric intensive care have reduced mortality but, unfortunately, one of the consequences is an increase in the number of patients with chronic diseases. It is generally agreed that home care of children requiring ventilatory support improves their outcomes and results in cost saving for the National Health Service. METHODS Since 1985, the Children's Hospital Bambino Gesù of Rome has developed a program of paediatric home care. The program is performed by a committed Home Health Care Team (HHCT) which selects the eligible patients for home care and trains the families to treat their child. During the period January 1985 to January 2001, 53 children with chronic respiratory failure were included in the home care program. Of these, seven patients were successively excluded and six died in our intensive care unit (ICU), while one still lives in our ICU since 1997. The results obtained in the remaining 46 children are reported. RESULTS The pathologies consisted of disorders of respiratory control related to brain damage (26%), upper airways obstructive disease (26%), spinal muscular atrophy (22%), myopathies and muscular dystrophies (6.5%), bronchopulmonary dysplasia (6.5%), tracheomalacia (6.5%), central hypoventilation syndrome (4.3%) and progressive congenital scoliosis (2.2%). Of these 46 patients, 34 children are mechanically ventilated and the median of their ICU stay was 109.5 days (range 54-214 days), while the remaining 12 children were breathing spontaneously and the median of their ICU stay was 90.5 days (range 61-134 days). We temporarily readmitted six patients to our ICU to perform scheduled otolaryngological surgery, eight patients for acute respiratory infections and two patients for deterioration of their neurological status due to high pressure hydrocephalus for placement of a ventriculoperitoneal shunt; these 16 patients were discharged back home again. Two other patients were readmitted for deterioration of their chronic disease and died in our ICU, while seven patients died at home. CONCLUSIONS Thirty-seven children are still alive at home and four of them improved their respiratory condition so that it was possible to remove the tracheostomy tube. Our oldest patient has now achieved 15 years of mechanical ventilation at home.
Collapse
Affiliation(s)
- L Appierto
- Children's Hospital Bambino Gesù, Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
30
|
Villani A, Onofri A, Bianchi R, Catena S, Cori M. [Determination of brain death in Intensive Pediatric Therapy]. Pediatr Med Chir 1998; 20:19-23. [PMID: 9658416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
The subject of this paper is to report our experience in the determination of brain death in infants and children. We have retrospectively examined the incidence of brain death occurred in 504 consecutive children admitted to multidisciplinary pediatric ICU at "Bambino Gesù" Hospital of Rome during the years 1994 to 1997. According to current Italian Law, brain death was declared in 8 children (1.6%), whose primary diagnoses were: Meningitis (3 cases); nontraumatic intracerebral hemorrhage (2 cases); medulloblastoma (1 case); brain metastasis of neuroblastoma (1 case); SIDS (1 case). All brain death diagnoses were made using clinical criteria and confirmatory tests. A difficult problem was met in achieving the required Pa-CO2 values higher than 60 mmHg without unduly lowering O2 saturation. In order to obtain easily this objective we have recently switched the ventilator to intermittent mandatory volume ventilation at a rate of five stroke per minute using a FiO2 of 1 before starting the apnea test. In infants younger than one year the required cerebral circulatory arrest was documented in the pericallosal artery by doppler ultrasonography performed through the fonticuli cranii. The absence of cerebral blood flow was recorded for one to five days after clinical and electroencephalographic diagnosis of brain death, causing an unnecessary prolonged rianimative support. This also confirms that in young infants brain death may occur without a marked increase of intracranial pressure. Last, but not least, we believe that particular attention must be paid to psycho-emotional conditions of parents as well as of intensivists and nurses especially when brain death must be assessed in children.
Collapse
Affiliation(s)
- A Villani
- Servizio di Anestesia e Rianimazione, Ospedale Pediatrico Bambino Gesu di Roma, Italia
| | | | | | | | | |
Collapse
|
31
|
Villani A, Vacca P, Onofri A, Cori M. [Disseminated mucormycosis. A rare case in pediatric intensive care]. Minerva Anestesiol 1997; 63:249-52. [PMID: 9489311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
A rare case of disseminated mucormycosis occurred in a 3-year-old boy suffering from a 4th degree neuroblastoma, treated with chemiotherapy and broad-spectrum antibiotics is reported. The child was admitted in the pediatric intensive care unit after surgical debridement of a wide part of the bowel showing necrosis and vessel thrombosis. After the histological diagnosis of mucormycosis in the gastrointestinal tract and the echographic detection of multiple mycotic localizations in the liver and kidneys, a treatment with high-dose amphotericin B was carried out. At the same time, the occurrence of anaerobiosis and/or acidosis as well as hyperglycemia was avoided in order to prevent the hyphae growth. This therapeutic strategy has been successful in preventing the infection spread, so that after 10 months from the discharge from the intensive care unit the child is in good health and the liver and kidney lesions are unchanged.
Collapse
Affiliation(s)
- A Villani
- Servizio di Anestesia e Rianimazione, Ospedale Pediatrico Bambino Gesu, IRCCS, Roma
| | | | | | | |
Collapse
|
32
|
Boglino C, Inserra A, Ciprandi G, Serventi P, Cacchione O, Onofri A, Boldrini R. [Interstitial pulmonary emphysema. Combined therapeutic approach in a retrospective multidisciplinary study]. Minerva Pediatr 1991; 43:675-83. [PMID: 1791794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Pulmonary interstitial emphysema (PIE) may occur spontaneously, as a complication of endotracheal tube displacement, intrauterine viral pneumonia or massive aspiration of formula. Nevertheless PIE occurs more frequently in neonates requiring mechanical ventilation for RDS. Untoward effects of large air collections in the extra-alveolar spaces are based on decreased perfusion and ventilation of the affected lung tissues, compression of adjacent pulmonary parenchyma and mediastinum, possible air embolism. Sometimes PIE spontaneously regress, but in some instances the process is self perpetuating, leading to an "air block syndrome". Fourteen (19.4%) of 72 infants ventilated for RDS in a three-year period had radiological evidence of PIE during the first few days of life. All 5 bilateral, 7 diffuse and 2 localized cases were treated with "vigorous pulmonary therapy". In addition to these procedures, 4 neonates were submitted to a selective bronchial intubation (SBI) and 5 different infants improved after HFV. No one of our patients underwent a surgical procedure. Infants with fine linear hyperlucencies improved sooner. All pneumothoraces (7 of 14) were preceded by X-ray appearances of PIE. Three neonates died. Mortality was observed in newborns with bilateral PIE, because of an intraventricular hemorrhage in two and an intractable under tension pneumothorax in one patient. Plain chest roentgenograms, histological pictures and treatment modalities of PIE remain separated from these considered for congenital lobar emphysema, congenital cystic adenomatoid malformation, bronchogenic cyst or lung sequestration. Surgical treatment of PIE is not as universally accepted as in congenital cystic lesions of the lung, in which it's mandatory.
Collapse
Affiliation(s)
- C Boglino
- Divisione di Chirurgia Generale Pediatrica, Ospedale Pediatrico, Bambino Gesù, Roma
| | | | | | | | | | | | | |
Collapse
|